Elite Pharmaceuticals

Elite Pharmaceuticals, Inc. is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products.

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-end Financial Results on June 17, 2019

[Elite Pharmaceuticals @ElitePharma]

@SquarespaceHelp sent informaiton via email through the contact page

[Elite Pharmaceuticals @ElitePharma]

@SquarespaceHelp Duplicate NS records are preventing email account added on Friday from working. How do I remove the NS records?

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals Enters into Strategic Marketing Alliance with Lannett For Generic Adderall® https://t.co/6KTqZOaaqG

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information https://t.co/JtF7In9Jfw

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2019 Financial Results on February 12, 2019 https://t.co/3IaubcLBgE

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals and SunGen Pharma File ANDA for an Antibiotic https://t.co/y3OD6r82Zi

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall® https://t.co/W9DFAzM7cS

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information https://t.co/adUciYuanw

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2019 Financial Results on November 12, 2018 https://t.co/TRHWbuWfdK

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals Launches Generic Methadone Tablets https://t.co/37I6df1XNB

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study https://t.co/JIYP7aFchr

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study https://t.co/rL3WReetJf

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2019 Ended June 30, 2018 and Provides Conference Call Information https://t.co/yuxZPMDlr1

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2019 Financial Results on August 10, 2018 https://t.co/7oWe7fninM

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals Appoints Aqeel A. Fatmi, Ph.D. to Its Board of Directors
https://t.co/tmTrEqSun3

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals Receives FDA Approval for Generic Methadone Hydrochloride Tablets https://t.co/MQSZ6gCldF

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2018 and Provides Conference Call Information https://t.co/s7KNk3pwIt

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals, Inc. Announces Passing of Board Member Eugene Pfeifer https://t.co/zDziz1BtBh

[Elite Pharmaceuticals @ElitePharma]

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Year-end Financial Results on June 15, 2018 https://t.co/qYJa9shoHr